Droebner Karoline, Haasbach Emanuel, Fuchs Cordula, Weinzierl Andreas O, Stevanovic Stefan, Büttner Mathias, Planz Oliver
Friedrich-Loeffler-Institut, Institute of Immunology, Paul-Ehrlich Str. 28, D-72076 Tübingen, Germany.
Vaccine. 2008 Dec 9;26(52):6965-74. doi: 10.1016/j.vaccine.2008.09.051. Epub 2008 Oct 9.
A H5N2 low pathogenic avian influenza virus (LPAIV) was isolated from a natural reservoir in Bavaria during a routine screen and was used as a vaccine strain to scrutinize the immune response involved in cross-protection after challenge infection with a H5N1 highly pathogenic avian influenza virus (HPAIV). The challenge virus was also isolated from a natural reservoir in Bavaria. Wild type, antibody deficient (muMT), CD4(-/-) and CD8(-/-) mice were infected with the apathogenic H5N2 vaccine strain and challenge infection with a 100-fold MLD(50) of the H5N1 strain was performed 80 days later. While 100% of the wild type and 100% of the CD8(-/-) mice stayed healthy, only 50% of the CD4(-/-) and none of the antibody deficient mice were protected. These results support the view that the humoral immune response and to certain extends the CD4(+) T helper cells are a prerequisite for cross-protective immunity against H5 influenza virus.
在一次常规筛查中,从巴伐利亚州的一个天然宿主中分离出一株H5N2低致病性禽流感病毒(LPAIV),并将其用作疫苗株,以研究用H5N1高致病性禽流感病毒(HPAIV)进行攻击感染后交叉保护所涉及的免疫反应。攻击病毒也从巴伐利亚州的一个天然宿主中分离得到。将野生型、抗体缺陷(muMT)、CD4(-/-)和CD8(-/-)小鼠感染无致病性的H5N2疫苗株,并在80天后用100倍半数致死剂量(MLD50)的H5N1株进行攻击感染。虽然100%的野生型和100%的CD8(-/-)小鼠保持健康,但只有50%的CD4(-/-)小鼠得到保护,而抗体缺陷小鼠无一得到保护。这些结果支持这样一种观点,即体液免疫反应以及在一定程度上CD4(+)辅助性T细胞是针对H5流感病毒产生交叉保护性免疫的先决条件。